Dobak John 4
4 · DermTech, Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Dobak John
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-03-09+56,407→ 700,252 total - Sale
Common Stock
2023-03-13$3.26/sh−1,559$5,082→ 698,693 total
Footnotes (2)
- [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) three thirty-sixths (3/36) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining thirty-three thirty-sixths (33/36) shall vest in eleven (11) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following June 5, 2023 until the final vesting date on March 5, 2026.
- [F2]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.